Přehled
Title: RAGE for Multiple Diseases: A Repurposing Drug Approach Using Artificial Intelligence and Systems Biology
Study program: Biomedical Technology and Bioinformatics
Supervisor: Sudeep Roy, PhD
Topic description:
The Receptor for Advanced Glycation End Products (RAGE) is a crucial target in the treatment of several diseases, as it is associated with numerous inflammatory and degenerative conditions. This project will utilize advanced artificial intelligence (AI) and systems biology approaches to explore the potential for drug repurposing targeting RAGE. The impetus for my current research arises from various factors.
RAGE is associated with various clinical conditions, including inflammatory illnesses, diabetes, Alzheimer’s disease, cardiovascular diseases, and cancer. Repurposing existing pharmaceuticals can significantly reduce the duration and cost of drug research, hence accelerating the introduction of innovative therapies for patients. Recent breakthroughs in AI and systems biology facilitate the prediction of drug-target interactions and the examination of complex biological systems. Innovative therapeutic approaches are urgently required, as numerous RAGE-associated illnesses lack viable treatments.
The applicant possesses an extensive background of collaboration with various national medical institutions, such as Mendel University, FNUSA, and ICRC Brno. Furthermore, he is collaborating with international partners located in Germany, the United Kingdom, and India, each of whom possesses specialized expertise and will contribute to different phases of the project’s execution.
Your task:
- To undertake original research by planning and carrying out a research project that adds to existing knowledge in one’s subject, with the end result being a dissertation or thesis.
- To become an expert independent researcher by developing advanced research abilities in specialised techniques, data analysis, and project management.
- To communicate discoveries through engaging with the academic community, presenting at conferences, and publishing research articles in peer-reviewed publications.
- Learn more about the field and get better at what you do while also getting experience in areas like leadership, mentoring, and teaching.
- Through networking and the acquisition of appropriate skills, establish a professional profile that is in line with aspirations for a career in academia, industry, or another field.
Requirements:
- Strong educational background in chemistry, bioinformatics, computer science, mathematics, physics, or biochemistry is required.
- A Master’s degree in a relevant field is frequently necessary, along with training or experience in cheminformatics, computational chemistry, or molecular modelling.
- Expertise in programming languages like Python.
- Proficiency in cheminformatics tools and methodologies, including molecular docking, pharmacophore modelling, machine learning, and data analysis. Expertise in computational drug design, database management, and statistical analysis for pharmaceutical applications.
- Demonstrates effective written and verbal communication abilities for publishing research findings and working in multidisciplinary teams.
We offer:
- HPC Clusters: Essential for large-scale chemical simulations, virtual screening, and machine
learning applications (GPU-accelerated servers with NVIDIA GPUs). - Modelling and Docking Software:
- Molecular Operating Environment (MOE): Provides tools for docking, pharmacophore
modelling, QSAR research, and structural optimisation. - AutoDock is an open-source docking software employed for virtual screening of small
compounds against protein targets. - Glide (docking), Maestro (visualisation), and Desmond (molecular dynamics) comprise
the Schrödinger Suite, a proprietary drug discovery platform. - PyMOL: Protein-ligand interaction visualisation.
- Molecular Operating Environment (MOE): Provides tools for docking, pharmacophore
- Engaged in interdisciplinary collaborations across biology, pharmacology, and computer science.
Contact: Sudeep Roy – roy@vut.cz
Relevant publications:
- Bhogal I, Pankaj V, Provaznik V and Roy S. In-Silico investigation of cholesterol-lowering drugs to find potential inhibitors of dehydrosqualene in staphylococcus aureus, 3Biotech, 2024.
- Roy S et al. CLICK-chemoproteomics and molecular dynamics simulation reveals pregnenolone targets and their binding conformations in Th2 cells, Frontiers in Immunology, 2023.
- Chaturvedi A et al. A novel synthesis of 2-arylbenzimidazoles in molecular sieves-MeOH system and their antitubercular activity, Bioorganic & Medicinal Chemistry, 2018.
How to apply:
Please apply and submit your motivation letter and CV via university website from April 1 to April 30, https://www.vut.cz/eprihlaska/cs/zadani/vybrat-obor/fakulta/5
Funding:
Funding is provided as a combination of part-time or full-time research projects and/or regular scholarships.